Breakthrough Research Unveils MicroRNAs' Role in Psychiatric and Neurodegenerative Diseases
Recent research has identified specific microRNAs that may influence the development of psychiatric and neurodegenerative diseases, offering new insights into gene regulation in brain health.
Recent groundbreaking research from UC Davis has identified specific microRNAs—small non-coding RNA molecules that regulate gene activity within cells—that may play a significant role in the development of psychiatric conditions such as bipolar disorder, depression, schizophrenia, PTSD, and neurodegenerative diseases like Parkinson's. This study marks a pioneering effort, being the first to link certain microRNAs directly to these complex disorders.
MicroRNAs function like molecular brakes, attaching themselves to messenger RNA (mRNA) to inhibit protein synthesis, thereby influencing cellular processes crucial for normal brain function. Abnormal regulation of microRNAs can disrupt this delicate balance, potentially leading to disease.
The study analyzed brain tissue from 604 older adults, focusing on the dorsolateral prefrontal cortex—a brain region involved in cognitive functions such as planning and working memory. Researchers identified 49 microRNAs associated with various brain traits and further pinpointed four microRNAs likely contributing to the risk of specific psychiatric and neurodegenerative conditions:
- miR-499a-5p: linked to bipolar disorder and schizophrenia
- miR-92b-3p: associated with Parkinson's disease
- miR-190b-5p: connected to PTSD
- miR-1908-5p: related to bipolar disorder and major depression
Interestingly, some microRNAs appear to influence multiple disorders, suggesting shared underlying mechanisms. The team also examined genetic variants called microRNA expression quantitative trait loci (miR-QTLs) that may affect microRNA levels, indicating genetic factors could influence disease susceptibility.
While the findings advance understanding significantly, the researchers acknowledged limitations, including the study's focus on older individuals of European ancestry and analysis confined to a single brain region. Future studies involving diverse populations and broader brain areas are essential for comprehensive insights.
Understanding how microRNAs regulate gene expression offers promising avenues for developing targeted therapies for these complex disorders. As Professor Thomas Wingo emphasized, microRNAs may hold the key to unraveling the genetic contributions to psychiatric and neurodegenerative diseases.
Source: https://medicalxpress.com/news/2025-06-brain-micrornas-contribute-psychiatric-neurodegenerative.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Stem Cell Microtissues Enable Personalized Drug Testing for Neurodegenerative Diseases
New stem cell-derived microtissues mimicking the human spinal cord offer personalized platforms for drug screening and studying neuroinflammation in ALS, paving the way for targeted therapies.
Innovative Low-Cost 'SimpleSilo' Could Transform Treatment for Babies with Gastroschisis Globally
A low-cost, easy-to-manufacture device called SimpleSilo offers a new hope for treating gastroschisis in low-resource settings, potentially saving thousands of infant lives globally. Developed by Rice University engineers, it replicates expensive silo bags at a fraction of the cost, making lifesaving neonatal care accessible worldwide.
Extended Walking Duration Associated with Reduced Risk of Chronic Low Back Pain
Extending daily walking duration beyond 100 minutes may significantly lower the risk of developing chronic low back pain, according to recent research. Incorporate more walking into your routine for better spine health.
BCG Revaccination Fails to Protect Against Persistent Tuberculosis Infection
Recent research reveals that BCG revaccination does not prevent sustained Mycobacterium tuberculosis infection, highlighting the need for new TB vaccines.